Company Quick10K Filing
Spotlight Innovation
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 36 $9
10-Q 2018-08-22 Quarter: 2018-06-30
10-Q 2018-05-21 Quarter: 2018-03-31
10-K 2018-04-17 Annual: 2017-12-31
10-Q 2017-11-20 Quarter: 2017-09-30
10-Q 2017-08-17 Quarter: 2017-06-30
10-Q 2017-05-22 Quarter: 2017-03-31
10-K 2017-04-27 Annual: 2016-12-31
10-Q 2016-11-18 Quarter: 2016-09-30
10-Q 2016-10-03 Quarter: 2016-06-30
10-Q 2016-09-27 Quarter: 2016-03-31
10-K 2016-08-31 Annual: 2015-12-31
10-Q 2015-11-18 Quarter: 2015-09-30
10-Q 2015-08-19 Quarter: 2015-06-30
10-Q 2015-05-18 Quarter: 2015-03-31
10-K 2015-04-15 Annual: 2014-12-31
10-Q 2014-11-19 Quarter: 2014-09-30
10-Q 2014-08-19 Quarter: 2014-06-30
10-Q 2014-05-20 Quarter: 2014-03-31
10-K 2014-05-20 Annual: 2014-03-31
10-Q 2013-11-19 Quarter: 2013-09-30
10-Q 2013-08-15 Quarter: 2013-06-30
10-Q 2013-05-20 Quarter: 2013-03-31
10-K 2013-04-16 Annual: 2012-12-31
10-Q 2012-12-19 Quarter: 2012-09-30
10-Q 2012-08-20 Quarter: 2012-06-30
10-Q 2012-05-21 Quarter: 2012-03-31
10-K 2012-05-16 Annual: 2011-12-31
10-Q 2011-11-15 Quarter: 2011-09-30
10-Q 2011-08-15 Quarter: 2011-06-30
10-Q 2011-05-20 Quarter: 2011-03-31
10-K 2011-04-05 Annual: 2010-12-31
10-Q 2010-11-09 Quarter: 2010-09-30
10-Q 2010-08-16 Quarter: 2010-06-30
10-Q 2010-05-24 Quarter: 2010-03-31
10-K 2010-04-14 Annual: 2009-12-31
8-K 2018-10-08 Officers
8-K 2018-08-13 Accountant, Exhibits
8-K 2018-06-20 Other Events, Exhibits
8-K 2018-04-18 Other Events, Exhibits
8-K 2018-01-11 Other Events, Exhibits
8-K 2018-01-02 Other Events

Spotlight Innovation Financials

STLT Metrics, Comps, Filings

Annual | Quarterly

Business

Spotlight Innovation Inc. (the "Company") is a pharmaceutical company focused on acquiring the intellectual property rights to innovative and proprietary therapeutics designed to address unmet medical needs with an emphasis on rare, emerging, or neglected diseases. In late summer/early fall of 2016 the Company changed its disease focus and has revised its product offerings including the addition of new indications and the elimination of previous programs.

The Company works to maintain a balanced portfolio of early- and late-stage product candidates. We conserve capital and streamline operations through cost-effective collaborations with:

· Contract research organizations (CROs) · Contract manufacturing organizations (CMOs) · Academic laboratories


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Wizard World (WIZD) 9,118 18% -3.1 -192% 1,462 6,772 10,561 1,866 -2,807 -2,807 8,626
Seychelle Environmental (SYEV) 9,058 51% 25.0 5% 4,366 877 2,700 1,386 220 276 6,883
HG Holdings (STLY) 8,975 3.4 14% 14,639 488 0 0 2,079 2,079 7,040
Techcare (TECR) 8,862 -17% -3.9 -286% 780 364 238 -41 -2,235 -2,235 8,632
ARC Group (ARCK) 8,851 18% 708.6 -5% 18,100 19,357 15,863 2,842 -980 12 8,596
Walker Innovation (WLKR) 8,841 -5.7 156,300,000% 0 0 -1,563 -1,563 8,841
Table Trac (TBTC) 8,831 90% 11.5 8% 6,664 2,566 5,953 5,383 559 752 8,625
Global Tech Industries Group (GTII) 8,789 -2.8 -1,271% 249 6,032 0 0 -3,162 -3,084 8,785
REGI (RGUS) 8,713 0% -5.1 -3,192% 63 2,699 60 0 -2,023 -2,023 10,363
Her Imports (HHER) 8,584 43% -1.2 -107% 6,998 1,048 12,143 5,195 -7,478 -7,183 8,476
Mikros Systems (MKRS) 8,584 62% 16.9 4% 3,799 1,341 7,702 4,809 169 411 6,932
Spotlight Innovation (STLT) 8,583 2% -4.7 -50% 7,186 8,344 32 1 -3,613 -2,846 13,490
Eternity Healthcare (ETAH) 8,553 -22.9 -14% 2,720 2,865 0 0 -388 -388 8,906
Conversion Labs (CVLB) 8,439 76% -43.3 -36% 2,199 3,628 10,077 7,665 -781 -195 8,444
Evans & Sutherland (ESCC) 8,326 37% 0.8 10% 26,605 18,602 35,911 13,420 2,649 3,433 2,884
Acorn Energy (ACFN) 8,282 63% -8.3 -11% 6,065 5,564 5,352 3,363 -677 -610 5,045
Jade Global Holdings (JADG) 8,280 -24.6 -1,450% 23 403 0 0 -336 -336 8,265
Magellan Gold (MAGE) 8,278 -766% -4.7 -140% 1,603 4,679 34 -258 -2,249 -1,777 8,276
Advanced Voice Recognition Systems (AVOI) 8,251 -153.0 -154% 42 240 0 0 -64 -54 8,245
PetVivo Holdings (PETV) 8,168 -3.3 -428% 738 1,893 0 -78 -3,159 -2,439 8,102

Balance Sheet ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Cash174199031366
Accounts Receivable0
Inventory193
PP&E932139
Assets1741587,1177,3268,5187,249
Accounts Payable173330141396593
Long-Term Debt951003001701,576
Liabilities-6691,0165,6974,0597,1957,1986,501
Stockholders' Equity686-1,012-5,5393,058131-1,307-1,556
Income Statement ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Revenue0000002
Cost of Revenue
Gross Profit
R&D275233742
SG&A7075675,1671,4874,6296,4323,759
Tax0000000
Net Income-4,508-600-6,810-3,625-8,042-16,726-6,170
Cash Flow ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Cash Operating-99-74-210-769-1,904-2,958-3,553
Cash Investing00-9318-11-616-57
Cash Financing105603167822,2063,8143,339